Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macrogol 4000 added to daily magnesium oxide for refractory chronic constipation or hypermagnesemia
jRCT1051190047Not yet recruiting
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of macrogol 4000 in chronic constipation. Primary endpoint: patient satisfaction. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
macrogol 4000
03
Conditions
chronic constipation
Beyond the preview
Go deeper on jRCT1051190047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051190047.